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Background: Plasma level of total homocysteine (tHcy) is negatively correlated with kidney function in general
population. However, the causal mechanism of this correlation is poorly understood. The purpose of this study is to
investigate the association of methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism, which is a
major genetic determinant of the plasma tHcy level, with estimated glomerular filtration rate (eGFR) in Chinese.
Methods: A total of 18 814 hypertensive patients (6 914 males, 11 900 females) were included in the study.
Results: Association between the eGFR and MTHFR C677T genotype was examined by sex-specific regression
analyses. In males, TT genotype was associated with 1.37 ml/min/1.73 m2 decrease in eGFR (p = 0.004) and with an
increased risk (OR = 1.32, p = 0.008) for the lowest quintile of eGFR after adjusting for age, BMI, and blood pressures.
However, such association was not observed in females (p > 0.05). This association suggests MTHFR C677T
polymorphism may play a role in the regulation of eGFR in males.
Conclusions: MTHFR 677 T is a risk allele for decreased kidney function in Chinese males, implicating this gene in
the pathogenesis of chronic kidney disease (CKD).
Keywords: MTHFR C677T polymorphism, eGFR, CKDBackground
Glomerular filtration rate estimated from serum creatinine
level (eGFR) is an important measurement of kidney func-
tion, and frequently used to define stages of chronic kidney
disease (CKD). Plasma level of total homocysteine (tHcy) is
negatively correlated with kidney function in general popu-
lation [1,2]. However, the causal mechanism of this correl-
ation is poorly understood. Significant loss of kidney
function will inevitably lead to hyperhomocysteinemia, as
frequently observed in patients with end-stage renal* Correspondence: hbshen@njmu.edu.cn; xinxxu@gmail.com; huoyong@263.
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reproduction in any medium, provided the ordisease. On the other hand, hyperhomocysteinemia could
induce glomerular injury in animal studies [3-7], though
it’s not clear if hyperhomocysteinemia play a pathogenic
role in decreased kidney function in humans. A recent pro-
spective study suggested tHcy is an independent predictor
for CKD [8].
Methylenetetrahydrofolate reductase (MTHFR) catalyzes
the conversion of 5,10-methylenetetrahydrofolate to 5-
methyltetrahydrofolate, a co-substrate for homocysteine
remethylation to methionine. C677T, a single nucleotide
polymorphism (C–>T) at nucleotide position 677, leads
to Ala–>Val codon substitution at amino acid position
222. MTHFR C677T is a major genetic determinant for
hyperhomocysteinemia, and has been shown to be asso-
ciated with risks for stroke, coronary heart disease, neural
tube defect, depression, schizophrenia, cancer, and atd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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investigated the association between C677T and kidney
function. Given the fact that kidney function and tHcy is
well correlated and that C677T is a major determinant of
tHcy, it would be interesting to test if C677T is associated
with kidney function in general populations.
In this report, we performed a cross-sectional analysis on




The study subjects were participants of an ongoing China
Stroke Primary Prevention Trial (CSPPT, clinicaltrials.
gov identifier: NCT00794885) in Lianyungang, Jiangsu
province of China. CSPPT is a multi-center randomized
controlled trial designed to confirm that enalapril male-
ate and folic acid tablets is more effective in preventing
stroke among the patientswith primary hypertensionwhen
compared with enalapril maleate. Details for inclusion/
exclusion criteria, treatment assignment, and outcome
measures of the trial were described elsewhere (http://
clinicaltrials.gov/ct2/show/NCT00794885). In the current
study, we included 18 814 subjects from Lianyungang
who participated in the screening phase of the trial and
had valid measurements of MTHFR C677T genotype and
baseline serum creatinine. The Human Subject Commit-
tee at the Biomedical Institute of the Anhui Medical Uni-
versity approved the study.
Data collection
Researchers went to the communities to screen local resi-
dents for hypertensive patients. Candidate hypertensive
patients were then invited to study centers for a formal
screening visit. Each participant was asked to fast after
10 PM the night before the visit. During the screening visit,
every participant gave the informed consent and then the
following baseline data were collected.
Questionnaires
Questionnaires were administered to collect information
on sociodemographic status, occupation, diet, lifestyle,
health behavior, medical history, and medication, as well as
reproductive history for women.
Anthropometry
Height was measured without shoes to the nearest 0.1 cm
on a portable stadiometer. Weight was measured in light
indoor clothing without shoes to the nearest 0.1 kg. WC
was measured as the minimum circumference between the
inferior margin of the ribcage and the crest of the iliac. Hip
circumference was measured at the level of maximum ex-
tension of the buttocks. BMI was calculated as weight/
height squared (kg/m2).Blood pressure
Resting blood pressures were measured three times in a
sitting position after 10 minutes of rest using a mercury
sphygmomanometer. Three blood pressure reads were
then averaged.
Phlebotomy
Venous blood was drawn from the forearm of each partici-
pant in the fasting status. Serum and plasma were sepa-
rated from blood cells in the field within 30 minutes and
kept frozen at −70°C.
Laboratory assays and GFR estimation
Serum creatinine was measured by a modified kinetic rate
Jaffe reaction method using a Dade Dimension Chemistry
Analyzer (Siemens, Germany). Serum glucose and total
cholesterol were also measured on the same analyzer.
Plasma homocysteine was measured by an enzyme-cycling
method using a Hitachi 7020 Automatic Analyzer (Hitachi,
Japan). DNA was extracted from leukocytes in peripheral
blood using standard techniques. MTHFR C677T genotype
was determined by Taqman assay designed and manufac-
tured by Applied Biosystems (Foster City, CA).
EGFR was estimated using the CKD-EPI equation as
following [15]: eGFR= 141 ×min (Scr/κ,1)α×max (Scr/
κ,1)-1.209 × 0.993Age × 1.018 [if female], where Scr is serum
creatinine (mg/dL), κ is 0.7 for females and 0.9 for males,
α is −0.329 for females and −0.411 for males.
Statistical analyses
The empirical sex-specific distributions of eGFR were esti-
mated using a kernel density estimating function. Geno-
type distribution was tested for Hardy-Weinberg
equilibrium (HWE) using a χ2 test. Sex-specific regression
analyses were performed to investigate the association be-
tween eGFR and C677T genotype and to estimate the gen-
otype’s odds ratio for low eGFR and CKD, adjusting for
age, BMI, and systolic and diastolic pressure. All the ana-
lyses were done using the statistical package R [16].
Results
This study includes 18814 hypertensive subjects (6914
males, 11900 females) from Lianyungang, China who parti-
cipated in the screening phase of CSPPT and had valid
measurements of baseline serum creatinine level and
MTHFR genotype. The phenotypic characteristics of sub-
jects were summarized in Table 1. In this population
females had considerably higher body mass index (BMI)
than males (26.1 vs 25.0 kg/m2), while the reverse was true
for blood creatinine and tHcy levels. The percentages of
subject with diabetic fasting plasma glucose level (FPG
≥7.0 mmol/L) were 11.7% and 13.3%, respectively, in males
and females. The percentages of subjects with CKD
(eGFR<60 ml/min/1.73 m2) were 3.1% and 3.4%,
Table 1 Phenotypic characteristics of study participants
Variables Male (N= 6914) Female (N= 11900)
Age, yrs 60.2 ±7.7 59.2 ± 7.5
BMI, kg/m2 25.0 ± 3.3 26.1 ± 3.7
SBP, mmHg 166.4 ± 20.9 169.1 ± 20.8
DBP, mmHg 97.1 ± 12.3 94.0 ± 11.5
Homocysteine, μmol/L 11.2 (9.3-14.2) 9.4 (7.8-11.6)
FPG, mmol/L 5.4 (4.9-6.2) 5.5 (4.9-6.2)
TC, mmol/L 5.2 (4.5-5.9) 5.4 (4.7-6.2)
Creatinine, mmol/L 71.0 (61.7-81.7) 56.3 (48.6-66.0)
eGFR, ml/min/1.73 m2 96.4 (87.9-104.2) 97.2 (87.0-104.5)





BMI body mass index, SBP systolic blood pressure, DBP diastolic blood
pressure, FPG fasting plasma glucose, TC total cholesterol, eGFR estimated
glomerular filtration rate, MTHFR methylenetetrahydrofolate reductase. Age,
BMI, and blood pressures were given by mean ± sd, serum markers were
given by median (Interquartile range, IQR).
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is more common than C allele, with an allele frequency of
0.51 and a TT genotype frequency of 0.26. The distribution
was in Hardy-Weinberg equilibrium (p >0.05).
The distributions of eGFR in both genders were quite
































Figure 1 The density curves of eGFR. eGFR = estimated glomerular filtra(Figure 1). Homocysteine and eGFR were inversely corre-
lated, with spearman correlation coefficient rho=−0.25
(−0.22 in males and −0.28 in females).
Taking eGFR as a quantitative outcome in the regression
analyses with adjustment for age, BMI, and systolic and
diastolic blood pressure, a significant association of
MTHFR C677T genotype and eGFR was observed in males
but not in females (Table 2). In males, while there was little
difference in eGFR among subjects with CC and CT geno-
types, TT homozygotes had 1.37 ml/min/1.73 m2 lower
eGFR than CC homozygotes (p=0.004). Similarly, when
dividing subjects in eGFR quintiles and comparing geno-
type frequencies, higher TT genotype frequencies were
observed in the low eGFR quintiles (Q1-3, Table 3) in
males. In females, genotype frequencies varied little across
eGFR quintiles. In males, TT genotype was associated with
a higher risk for decreased kidney function after adjusting
for age, BMI, and blood pressures, with OR=1.32 (95%
CI:1.08-1.62, p= 0.008) for the lowest quintile of eGFR,
OR=1.25 (95% CI:1.11-1.41, p= 0.0003) for the lower half
of eGFR, and OR=1.21 (95% CI: 0.89-1.63, p= 0.22) for
CKD defined as eGFR<60 ml/min/1.73 m2. No such asso-
ciation was observed in females.
Since C677T genotype, homocysteine, and eGFR are sig-
nificantly correlated, it is difficult to segregate the individ-
ual effect of genotype and homocysteine on eGFR in a
regression analysis. Nevertheless, regression analysis of
eGFR with an interactive term between genotype and
homocysteine (Table 4) revealed the similar sex-specific100 120 140 160
GFR
tion rate, eGFR was in unit of ml/min/1.73 m2.
Table 2 Regression analysis of eGFR and MTHFR C677T genotype
MTHFR C677T genotype Males Females
Mean eGFR β SE P Mean eGFR β SE P
CC 95.5 - - 94.7 - -
CT 95.3 −0.17 0.42 0.68 94.3 −0.42 0.33 0.20
TT 94.1 −1.37 0.47 0.004 94.7 −0.19 0.37 0.61
MTHFR methylenetetrahydrofolate reductase, eGFR estimated glomerular filtration rate, β regression coefficient, SE standard error, eGFR was in unit of ml/min/
1.73 m2. Regression was done with adjustment for age, BMI, systolic and diastolic blood pressures.
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levels were inversely associated with eGFR in both genders.
A significant interaction between TT genotype and homo-
cysteine on eGFR was observed only in males: the regres-
sion coefficient of homocysteine was attenuated in TT
homozygotes compared with CC homozygotes (p= 0.002).
Discussion
In this report, we have demonstrated that MTHFR C677T
genotype is associated with eGFR in Chinese males, but
not in females. The association still holds after adjusting
for age, BMI, and blood pressures.
The Val form of MTHFR encoded by the 677 T allele is
thermolabile and has reduced enzymatic activity [9]. The
degree of enzyme thermolability (assessed as residual activ-
ity after heat inactivation) is much greater in 677TT indivi-
duals (18-22%) compared with C677T (56%) and C677C
(66-67%). The allele frequency of 677 T varies with popula-
tions, ranging from less than 10% in African to 50% in
Chinese [12]. Consistent with previous reports, in our
study samples 677 T is the major allele with an allele fre-
quency of 0.516 and TT homozygote frequency of 0.26.
Many cross-sectional studies showed that plasma tHcy
and kidney function was negatively correlated. For ex-
ample, in NHANES III study [1], the risk for CKD defined
as eGFR<60 ml/min/1.73 m2 in individuals with high tHcy
level (>11umol/L) was 40 times higher than those with low
tHcy level (<7umol/L). However, it’s still not clear if hyper-
homocysteinemia is the true effector that leads to
decreased kidney function or it is simply a marker for kid-
ney function. A recent prospective study in the Framing-
ham cohort demonstrated that baseline homocysteine is anTable 3 MTHFR C677T genotype frequencies in eGFR quintiles
eGFR Quintiles Male
N CC(%) CT(%)
Q1 (0-20%) 2371 22.6 48.5
Q2 (20-40%) 2371 23.6 48.9
Q3 (40-60%) 2371 23.0 48.7
Q4 (60-80%) 2371 25.2 50.1
Q5 (80-100%) 2372 25.0 50.5
MTHFR methylenetetrahydrofolate reductase, eGFR estimated glomerular filtration rindependent risk predictor for CKD and urine microalbu-
minuria [8]. In animal studies, induced hyperhomocystei-
nemia could cause podocyte injury and glomerulosclerosis
[5-7]. Feeding rats with methionine induced hyperhomo-
cysteinemia and resulted in significant decrease of GFR.
In the current study, we explored association between
MTHFR C677T and kidney function indexed by eGFR in a
large Chinese sample, and found a significant association
in males but not in females. In males, the association
model was apparently recessive. While individuals with CC
and CT had similar eGFRs, individuals with TT were asso-
ciated with 1.37 ml/min/1.73 m2 lower value in eGFR, and
an increased risk for decreased kidney function defined by
bottom 20 or 50 percentiles. Of our study subjects, 3.3%
had CKD with eGFR<60 ml/min/1.73 m2, which is slightly
higher than the 2.53% prevalence rate in China adults aged
35–74 years reported from the InterAsia [17], partly due to
the hypertensive nature of our study sample. Our study
also suggested TT genotype was associated with an in-
crease risk of CKD (OR=1.21, p = 0.22), though it didn’t
reach statistical significance probably due to the low per-
centage of CKD in our sample.
We have also observed a significant interaction between
C677T genotype and homocysteine on eGFR in males. In
males, the apparent effect size of homocysteine on eGFR
was significantly reduced in TT homozygotes compared
with subjects with CC genotype. In other words, the TT ef-
fect size was bigger in subjects with lower homocysteine
level. However, due to collinearity, it is difficult to segregate
their effects under current study design. Another limitation
of our study is the study population was hypertensive; the
findings from this study may not be generalizable toFemale
TT(%) N CC(%) CT(%) TT(%)
28.9 1375 23.6 50.6 25.8
27.6 1375 22.9 50.4 26.7
28.4 1375 24.0 49.1 26.9
24.7 1375 21.9 51.3 26.7
24.7 1375 25.3 49.7 25.0
ate.
Table 4 Regression analysis of eGFR with interaction
between homocysteine and MTHFR C677T genotype
Males Females
β SE P β SE P
CT −3.54 3.12 0.26 −0.83 2.30 0.72
TT −9.39 3.16 0.003 −0.79 2.48 0.75
log(Hcy) −6.73 1.15 5.7x10-9 −7.10 0.89 1.4x10-15
CT:log(Hcy) 1.52 1.32 0.25 0.42 1.04 0.69
TT:log(Hcy) 3.91 1.29 0.0024 1.04 1.08 0.34
Regression was done with adjustment for age, BMI, systolic and diastolic blood
pressures (coefficients not shown). Log(Hcy) was the natural log of plasma
homocysteine in μmol/L. β regression coefficient, SE standard error, eGFR was
in unit of ml/min/1.73 m2.
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would be helpful.
Conclusions
In conclusion, we have demonstrated MTHFR 677 T is a
risk allele for decreased kidney function in hypertensive
Chinese males, implicating this gene in the pathogenesis of
CKD. Given the relationship among MTHFR, tHcy and
eGFR, it would be temptational to speculate that tHcy me-
diate MTHFR’s effect on CKD. The ongoing CSPPT trial,
which is essentially a homocysteine-lowering trial, should
provide a more definitive answer when it completes.
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